Abcam (OTCMKTS:ABCZF – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Abcam to related companies based on the strength of its valuation, earnings, risk, dividends, analyst recommendations, institutional ownership and profitability. Insider & Institutional Ownership 43.6% of Abcam shares are […]
Abcam (OTCMKTS:ABCZF – Free Report) is one of 360 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Abcam to related companies based on the strength of its profitability, analyst recommendations, dividends, earnings, valuation, institutional ownership and risk. Profitability This table compares Abcam and its competitors’ net […]
Abcam (OTCMKTS:ABCZF – Free Report) is one of 362 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Abcam to similar businesses based on the strength of its valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and earnings. Analyst Recommendations This is a summary of recent ratings […]
Shares of Abcam plc (LON:ABC – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,252.97 ($16.03) and traded as low as GBX 1,115 ($14.27). Abcam shares last traded at GBX 1,226 ($15.69), with a volume of 6,372,291 shares trading hands. Abcam […]
Royal Bank of Canada cut shares of Abcam (NASDAQ:ABCM – Get Rating) from an outperform rating to a sector perform rating in a research report released on Tuesday morning, MarketBeat Ratings reports. Separately, Bank of America upgraded shares of Abcam from a neutral rating to a buy rating in a research note on Friday, June […]